CLINICAL_TRIALS
trial_result
· 2009-10-14
Clinical Trial Update: The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer
Summary
A completed study assessing the clinical and economic impact of pharmacogenomic testing for tamoxifen metabolism in postmenopausal women taking tamoxifen to pre…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medco Health Solutions, Inc. | Conditions: Breast Neoplasms, Tamoxifen | Status: COMPLETED